{"id":244784,"date":"2025-02-23T05:44:05","date_gmt":"2025-02-23T05:44:05","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2025\/02\/23\/life-saving-simple-blood-test-could-transform-and-personalise-cancer-care-if-trial-succeeds\/"},"modified":"2025-02-23T05:44:06","modified_gmt":"2025-02-23T05:44:06","slug":"life-saving-simple-blood-test-could-transform-and-personalise-cancer-care-if-trial-succeeds","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2025\/02\/23\/life-saving-simple-blood-test-could-transform-and-personalise-cancer-care-if-trial-succeeds\/","title":{"rendered":"&#8216;Life-saving&#8217; simple blood test could transform and personalise cancer care if trial succeeds"},"content":{"rendered":"<div style=\"text-align:center\"><img decoding=\"async\" src=\"https:\/\/i3.wp.com\/e3.365dm.com\/25\/02\/768x432\/skynews-matthew-krebs-dr-cancer_6835565.jpg?20250221132601&amp;ssl=1\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"&#8216;Life-saving&#8217; simple blood test could transform and personalise cancer care if trial succeeds\" title=\"&#8216;Life-saving&#8217; simple blood test could transform and personalise cancer care if trial succeeds\" \/><\/div><p> <br \/>\n<\/p>\n<div data-component-name=\"ui-article-body\" data-highlight-intro=\"true\">\n<p>Personalised cancer treatment, matched to a patient via a simple blood test, is being hailed as &#8220;life-saving&#8221;, following an initial study.<\/p>\n<p>The Target National trial, being conducted at The Christie hospital in Manchester, analyses a patient&#8217;s DNA to determine what type of therapy will work best for them.<\/p>\n<p>If successful, researchers hope the procedure could become &#8220;routinely available on the NHS&#8221;.<\/p>\n<p>Dr Matthew Krebs, the study&#8217;s chief investigator, tells Sky News its research was making &#8220;precision medicine&#8221; more accessible for a wider range of cancer patients.<\/p>\n<p>&#8220;There are tiny bits of DNA which come off the cancer that circulate around in the bloodstream,&#8221; he explains, &#8220;so we can extract the DNA that specifically comes from the cancer.&#8221;<\/p>\n<div class=\"sdc-article-widget sdc-article-image\">\n<figure class=\"sdc-article-image__figure\">\n<div class=\"sdc-article-image__wrapper\" data-aspect-ratio=\"16\/9\"><\/div><figcaption class=\"ui-media-caption\">\n        <span class=\"u-hide-visually\">Image:<\/span><br \/>\n        <span class=\"ui-media-caption__caption-text\">Dr Matthew Krebs, the chief investigator of the Target National trial, says patients can get &#8216;more personalised&#8217; treatment<br \/>\n        <\/span><br \/>\n      <\/figcaption><\/figure>\n<\/div>\n<p>That DNA is then analysed, allowing doctors to see its specific mutations and suggest bespoke treatment.<\/p>\n<p>Dr Krebs says that means &#8220;rather than just treating generically with chemotherapy-type drugs&#8221; the patient gets a treatment &#8220;that&#8217;s more personalised to them&#8221;.<\/p>\n<p>Although genetic and DNA testing for cancer patients is already being carried out in hospitals, typically the sample is collected using a biopsy.<\/p>\n<p>That can involve surgery, be intrusive, painful and &#8211; in some cases &#8211; delayed.<\/p>\n<p><strong>Read more from Katerina Vittozzi:<br \/><a href=\"https:\/\/news.sky.com\/story\/almost-one-in-five-teachers-have-seen-students-with-knives-in-englands-schools-sky-news-survey-finds-13308541\" target=\"_blank\" rel=\"noopener\">Stabbed teacher speaks out<\/a><br \/><a href=\"https:\/\/news.sky.com\/story\/more-british-people-than-ever-trapped-in-modern-slavery-as-sky-news-joins-police-on-abattoir-raid-13300349\" target=\"_blank\" rel=\"noopener\">Sky News joins police slavery raid at abattoir<\/a><br \/><a href=\"https:\/\/news.sky.com\/story\/living-with-a-sex-offender-why-i-stayed-with-my-husband-after-he-was-caught-with-child-abuse-images-13020279\" target=\"_blank\" rel=\"noopener\">Why wife stayed with husband after child abuse images found<\/a><\/strong><\/p>\n<div class=\"sdc-article-widget sdc-article-image\">\n<figure class=\"sdc-article-image__figure\">\n<div class=\"sdc-article-image__wrapper\" data-aspect-ratio=\"16\/9\">\n          <img decoding=\"async\" class=\"sdc-article-image__item\" loading=\"lazy\" intrinsicsize=\"768x432\" src=\"https:\/\/e3.365dm.com\/25\/02\/768x432\/skynews-target-national-vittozzi_6835560.jpg?20250221132440\" srcset=\"https:\/\/e3.365dm.com\/25\/02\/384x216\/skynews-target-national-vittozzi_6835560.jpg?20250221132440 380w, https:\/\/e3.365dm.com\/25\/02\/768x432\/skynews-target-national-vittozzi_6835560.jpg?20250221132440 760w, https:\/\/e3.365dm.com\/25\/02\/1600x900\/skynews-target-national-vittozzi_6835560.jpg?20250221132440 1024w, https:\/\/e3.365dm.com\/25\/02\/2048x1152\/skynews-target-national-vittozzi_6835560.jpg?20250221132440 2048w\" sizes=\"(min-width: 1024px) 1024px, 100vw\" alt=\"The trial uses blood tests to determine how cancer patients can have bespoke treatment\"\/>\n    <\/div><figcaption class=\"ui-media-caption\">\n        <span class=\"u-hide-visually\">Image:<\/span><br \/>\n        <span class=\"ui-media-caption__caption-text\">The trial analyses a patient&#8217;s DNA to determine what type of therapy will work best for them<br \/>\n        <\/span><br \/>\n      <\/figcaption><\/figure>\n<\/div>\n<p><strong>&#8216;It&#8217;s been life-saving&#8217;<\/strong><\/p>\n<p>The Target National study, funded by The Christie Charity and the Sir Bobby Robson Foundation, hopes to recruit 6,000 patients, to examine if the blood-test route, in effect a &#8220;liquid biopsy&#8221;, improves patient outcomes.<\/p>\n<p>Dr Krebs says they know that the blood test route &#8220;won&#8217;t work for everyone&#8221;, but in some cases, it has already enabled patients with advanced cancers to be matched to drug trials.<\/p>\n<p>Pamela Garner-Jones, 78, was told her stage four cervical cancer was &#8220;inoperable&#8221; and &#8220;no longer responding to treatment&#8221;.<\/p>\n<p>&#8220;They were talking about palliative care,&#8221; she tells Sky News. &#8220;I thought they were making it up, I couldn&#8217;t believe it.&#8221;<\/p>\n<p>At that point, Ms Garner-Jones was offered a place on the Target National study. Her blood test matched her to a new immunotherapy drug trial, that saw her tumour shrink by two-thirds.<\/p>\n<div class=\"sdc-article-widget sdc-article-image\">\n<figure class=\"sdc-article-image__figure\">\n<div class=\"sdc-article-image__wrapper\" data-aspect-ratio=\"16\/9\">\n          <img decoding=\"async\" class=\"sdc-article-image__item\" loading=\"lazy\" intrinsicsize=\"768x432\" src=\"https:\/\/e3.365dm.com\/25\/02\/768x432\/skynews-cancer-vittozzi-pamela-garner-jones_6835559.jpg?20250221132322\" srcset=\"https:\/\/e3.365dm.com\/25\/02\/384x216\/skynews-cancer-vittozzi-pamela-garner-jones_6835559.jpg?20250221132322 380w, https:\/\/e3.365dm.com\/25\/02\/768x432\/skynews-cancer-vittozzi-pamela-garner-jones_6835559.jpg?20250221132322 760w, https:\/\/e3.365dm.com\/25\/02\/1600x900\/skynews-cancer-vittozzi-pamela-garner-jones_6835559.jpg?20250221132322 1024w, https:\/\/e3.365dm.com\/25\/02\/2048x1152\/skynews-cancer-vittozzi-pamela-garner-jones_6835559.jpg?20250221132322 2048w\" sizes=\"(min-width: 1024px) 1024px, 100vw\" alt=\"Pamela Garner-Jones, 78, was told her Stage 4 cervical cancer was &quot;inoperable&quot; - but a trial blood test helped personalise her care with a new drug, which shrunk her tumour\"\/>\n    <\/div><figcaption class=\"ui-media-caption\">\n        <span class=\"u-hide-visually\">Image:<\/span><br \/>\n        <span class=\"ui-media-caption__caption-text\">Pamela Garner-Jones was told her cervical cancer was &#8216;inoperable&#8217; but a trial blood test helped her access a new drug, which shrunk her tumour<br \/>\n        <\/span><br \/>\n      <\/figcaption><\/figure>\n<\/div>\n<p>&#8220;Honestly, I couldn&#8217;t ask for anything more,&#8221; she says. &#8220;I&#8217;ve got more energy, my appetite&#8217;s back &#8211; it&#8217;s been life-saving.&#8221;<\/p>\n<p>&#8220;It&#8217;s just a simple blood test and you&#8217;re not pumped full of no end of drugs,&#8221; she adds.<\/p>\n<p>Ms Garner-Jones says she is now looking forward to a holiday with friends, meals out and being able to spend time in her garden.<\/p>\n<p>&#8220;I&#8217;m made up,&#8221; she says. &#8220;Like a dog with two tails!&#8221;<\/p>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/news.sky.com\/story\/life-saving-simple-blood-test-could-transform-and-personalise-cancer-care-if-trial-succeeds-13313872\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Personalised cancer treatment, matched to a patient via a simple blood test, is being hailed as &#8220;life-saving&#8221;, following an initial study. The Target National trial, being conducted at The Christie hospital in Manchester, analyses a patient&#8217;s DNA to determine what type of therapy will work best for them. If successful, researchers hope the procedure could [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":244785,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","fifu_image_url":"https:\/\/e3.365dm.com\/25\/02\/768x432\/skynews-matthew-krebs-dr-cancer_6835565.jpg?20250221132601","fifu_image_alt":"","footnotes":""},"categories":[607],"tags":[1491,281,3755,16285,190135,6634,28698,848,27084,6230],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/244784"}],"collection":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/comments?post=244784"}],"version-history":[{"count":1,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/244784\/revisions"}],"predecessor-version":[{"id":244786,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/244784\/revisions\/244786"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media\/244785"}],"wp:attachment":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media?parent=244784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/categories?post=244784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/tags?post=244784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}